UNLIMITED TURBO LONG - PFIZER INC | Market Closed - Deutsche Boerse AG 20:50:28 14/06/2024 BST | ||
| 0.57 EUR | -1.72% |
|
| Current month | -13.64% | ||
| 1 month | -13.64% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 0.57 | -1.72% |
| 13/06/24 | 0.58 | +1.75% |
| 12/06/24 | 0.57 | -6.56% |
| 11/06/24 | 0.61 | -1.61% |
| 10/06/24 | 0.62 | -7.46% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| WKN | PF4B3T |
| ISIN | DE000PF4B3T0 |
| Date issued | 19/11/2020 |
| Strike | 21.67 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.69 € |
|---|---|
| Lowest since issue | 0.36 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.53
USD
Average target price
31.92
USD
Spread / Average Target
+15.93%
- Stock Market
- Certificates
- Certificat